Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376851 · ClinicalTrials.gov registry record
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
A clinical trial of Coronary Artery Disease, sponsored by HeartFlow.
- Active
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT06376851 is a study of Coronary Artery Disease that is active but no longer recruiting, run by HeartFlow. The registered enrollment target is 20,000 participants, above the 1,196-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1572% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06376851, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by HeartFlow.
- ACTIVE NOT RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of HeartFlow's DECIDE Registry is to collect observational data about the management of patients before and after HeartFlow Artificial Intelligence-Quantitative Coronary Plaque Analysis (AI-QCPA).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST AI-enabled quantitative coronary plaque analysis (AI-QCPA)
Study Locations (1)
North Carolina
- Moses Cone Memorial Hospital - Greensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2030-03-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06376851
The ClinicalTrials.gov registry entry for NCT06376851 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,196-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1572% higher). The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which AI-enabled quantitative coronary plaque analysis (AI-QCPA) is the first listed.
NCT06376851 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06376851 about?
NCT06376851 is a clinical study titled "AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management". The objective of HeartFlow's DECIDE Registry is to collect observational data about the management of patients before and after HeartFlow Artificial Intelligence-Quantitative Coronary Plaque Analysis (AI-QCPA).
What is the current status of trial NCT06376851?
This trial is currently active not recruiting. The enrollment target is 20,000 participants. The study started on 2024-03-27. Estimated completion is 2030-03-27.
What conditions does trial NCT06376851 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT06376851?
The interventions under investigation include: AI-enabled quantitative coronary plaque analysis (AI-QCPA) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06376851?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06376851 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.